TMEM106B对帕金森病和额颞叶痴呆认知的影响
本研究纵向随访870例帕金森病、额颞叶痴呆、阿尔茨海默病、记忆型轻度认知障碍和正常对照受试者,评估TMEM106B rs1990622基因型对认知下降的影响。结果显示,与FTD风险增加相关的rs1990622T等位基因在帕金森病患者中与MMSE下降更快相关,但在AD或MCI中无此关联;该效应在DRS-2和PPMI队列的MoCA中得到验证。
要点
- TMEM106B rs1990622T等位基因与帕金森病患者MMSE下降更快相关。
- 该基因型效应在AD或MCI患者中未观察到。
- TMEM106B是帕金森病认知轨迹的遗传修饰因子。
核心结论
- TMEM106B是帕金森病认知轨迹的遗传修饰因子,与认知下降更快相关。
研究设计与样本
- 在宾夕法尼亚大学纵向随访870例受试者,包括PD 179例、FTD 179例、AD 300例、MCI 75例和正常对照137例。
- 所有参与者每年进行MMSE评估,中位随访3.0年,并对TMEM106B rs1990622进行基因分型。
- 分析扩展至DRS-2和MoCA认知工具,并在PPMI国际验证队列(N=371)中确认。
主要发现
- 在PD受试者中,rs1990622T等位基因与MMSE随时间下降更快相关,但在AD或MCI受试者中无此关联。
- 在FTD受试者中,rs1990622T仅在小等位基因rs1990622C显性模型下与MMSE下降更快相关。
- 在UPenn队列的PD患者中,rs1990622T携带者显示DRS-2评分纵向下降更快。
- 在PPMI队列中,TMEM106B风险等位基因携带者显示MoCA评分纵向下降更快。
临床怎么用
- TMEM106B rs1990622基因型可能有助于识别帕金森病中认知下降风险较高的患者。
- 在帕金森病患者中,携带rs1990622T等位基因提示认知轨迹可能更差,需加强认知监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Common variants near TMEM106B associate with risk of developing frontotemporal dementia (FTD). Emerging evidence suggests a role for TMEM106B in neurodegenerative processes beyond FTD. We evaluate the effect of TMEM106B genotype on cognitive decline across multiple neurogenerative diseases. METHODS: We longitudinally followed 870 subjects with diagnoses of Parkinson disease (PD; n = 179), FTD (n = 179), Alzheimer disease (AD; n = 300), memory-predominant mild cognitive impairment (MCI; n = 75), or neurologically normal control subjects (NC; n = 137) at the University of Pennsylvania (UPenn). All participants had annual Mini-Mental State Examination (MMSE; median follow-up duration = 3.0 years) and were genotyped at TMEM106B index single nucleotide polymorphism rs1990622. Genotype effects on cognition were confirmed by extending analyses to additional cognitive instruments (Mattis Dementia Rating Scale-2 [DRS-2] and Montreal Cognitive Assessment [MoCA]) and to an international validation cohort (Parkinson's Progression Markers Initiative [PPMI], N = 371). RESULTS: The TMEM106B rs1990622T allele, linked to increased risk of FTD, associated with greater MMSE decline over time in PD subjects but not in AD or MCI subjects. For FTD subjects, rs1990622T associated with more rapid decrease in MMSE only under the minor-allele, rs1990622C , dominant model. Among PD patients, rs1990622T carriers from the UPenn cohort demonstrated more rapid longitudinal decline in DRS-2 scores. Finally, in the PPMI cohort, TMEM106B risk allele carriers demonstrated more rapid longitudinal decline in MoCA scores. INTERPRETATION: Irrespective of cognitive instrument or cohort assessed, TMEM106B acts as a genetic modifier for cognitive trajectory in PD. Our results implicate lysosomal dysfunction in the pathogenesis of cognitive decline in 2 different proteinopathies. ANN NEUROL 2019;85:801-811.
引用
- Tropea TF, Mak J, Guo MH, et al. TMEM106B Effect on cognition in Parkinson disease and frontotemporal dementia. Ann Neurol. 2019. PMID: 30973966. doi:10.1002/ana.25486
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。